Vaccine, 0264-410X
Journal
Publications
- Article › Research › Not peer-reviewed
- Published
A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004
Rachel Jordan, Jonathan Ayres, Peymane Adab, Richard McManus & KK Cheng, 14 Nov 2007, In: Vaccine. 25, 46, p. 7909-13 5 p.Research output: Contribution to journal › Article
- Published
A randomised double-bline controlled trial of the immunogenicity and tolerability of a meningococal group C conjugate vaccine in young British infants
Jon Deeks, 1 Jan 2001, In: Vaccine. 2001, 19, p. 1232-1238 7 p.Research output: Contribution to journal › Article
- Published
Corrigendum to 'Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial' [Vaccine 34 (2016) 2679-2685]
Joanna Long, Mark Drayson, Angela Taylor, Kai Toellner, Janet Lord & Anna Whittaker, 14 Sep 2016, In: Vaccine. 34, 40, p. 4842Research output: Contribution to journal › Article
- Published
Factors influencing influenza vaccination uptake in an elderly, community-based sample
Victoria Burns, Chris Ring & Doug Carroll, 20 May 2005, In: Vaccine. 23, p. 3604-3608 5 p.Research output: Contribution to journal › Article
- Published
Innate and adaptive cellular immunity in flavivirus-naive human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3
G Neil Thomas, 5 Jun 2006, In: Vaccine. 24, p. 4914-4926 13 p.Research output: Contribution to journal › Article
- Published
Knowledge and acceptability of the HPV vaccine by school children and their parents in Birmingham
Geoff Brown, 1 Feb 2010, In: Vaccine. 28, 6, p. 1440-1446 7 p.Research output: Contribution to journal › Article
- Published
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe.
Mark Jit, 19 Oct 2009, In: Vaccine. 27, 44, p. 6121-8 8 p.Research output: Contribution to journal › Article
- Published
The ethics of mandatory vaccination against influenza for health care workers
Angus Dawson, 1 Jan 2008, In: Vaccine. 26, 44, p. 5562-5566 5 p.Research output: Contribution to journal › Article
- Published
Therapeutic vaccines: a solution to the prevention problem?
Angus Dawson, 18 Mar 2005, In: Vaccine. 23, 17-18, p. 2363-6 4 p.Research output: Contribution to journal › Article
- Published
- Published
Vaccinating healthcare workers against influenza to protect the vunerable - is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation
Amanda Burls, Rachel Jordan, Pelham Barton, Esther Albon, 8 May 2006, In: Vaccine. 24, 19, p. 4212-4221 10 p.Research output: Contribution to journal › Article
- Published
Widening inequalities in MMR vaccine uptake rates among ethnic groups in an urban area of the UK during a period of vaccine controversy (1994-2000)
Richard Wilson, 23 Oct 2007, In: Vaccine. 25, 43, p. 7516-9 4 p.Research output: Contribution to journal › Article
- Article › Research › Peer-reviewed
- Published
A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen
Timothy Mitchell, 10 Feb 2010, In: Vaccine. 28, 6, p. 1620-34 15 p.Research output: Contribution to journal › Article › peer-review
- Published
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults
Paul Moss, 8 Mar 2016, In: Vaccine. 34, 11, p. 1412-21 10 p.Research output: Contribution to journal › Article › peer-review
- Published
A novel approach to generating morbillivirus vaccines: negatively marking the rinderpest vaccine
Dalan Bailey, 2 Mar 2012, In: Vaccine. 30, 11, p. 1927-35 9 p.Research output: Contribution to journal › Article › peer-review
- Published
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults
Paul Moss, 22 Jan 2020, In: Vaccine. 38, 4, p. 779-789 11 p.Research output: Contribution to journal › Article › peer-review
- Published
Acute exercise enhancement of pneumococcal vaccination response: a randomised controlled trial of weaker and stronger immune response
John Campbell, Mark Drayson, 5 Oct 2012, In: Vaccine. 30, 45, p. 6389-95 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Antibody response to vaccination and psychological stress in humans Relationships and mechanisms
Victoria Burns, Doug Carroll, Chris Ring & Mark Drayson, 1 Jun 2003, In: Vaccine. 21, 19-20, p. 2523-2534 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis
Hannah Batchelor, 29 Oct 2008, In: Vaccine. 26, 46, p. 5791-5797 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro
Timothy Mitchell, 8 Nov 2011, In: Vaccine. 29, 48, p. 8780-2 3 p.Research output: Contribution to journal › Article › peer-review
- Published
Cost-effectiveness analysis of maternal immunisation against group B streptococcus (GBS) disease: a modelling study
Hareth Al-Janabi, 12 Nov 2018, In: Vaccine. 36, 46, p. 7033-7042Research output: Contribution to journal › Article › peer-review
- Published
Dissecting the components of the humoral immune response elicited by DNA vaccines
Timothy Mitchell, Bernard Burke, 6 Feb 2006, In: Vaccine. 24, 6, p. 776-84 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Dysfunctional Labor: Case Definition & Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data
Sara Kenyon, 4 Dec 2017, In: Vaccine. 35, Issue 48, Part A, p. 6538-6545Research output: Contribution to journal › Article › peer-review
- Published
Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses
Timothy Mitchell, 30 Mar 2015, In: Vaccine. 33, 14, p. 1711-1718 8 p.Research output: Contribution to journal › Article › peer-review
- Published
HPV? Never heard of it! A systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination
Sarah Damery, 9 Sep 2013, In: Vaccine. 31, p. 5152-5167 15 p.Research output: Contribution to journal › Article › peer-review
- Published
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
Zania Stamataki, Peter Balfe, Jane McKeating, 7 Nov 2007, In: Vaccine. 25, 45, p. 7773-84 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis
Timothy Mitchell, 10 Oct 2007, In: Vaccine. 25, 41, p. 7197-205 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Morning vaccination enhances antibody response over afternoon vaccination: a cluster-randomised trial
Joanna Long, Mark Drayson, Angela Taylor, Kai Toellner, Janet Lord & Anna Whittaker, 23 May 2016, In: Vaccine. 34, 24, p. 2679-2685 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Novel mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus pneumoniae
Timothy Mitchell, 19 Apr 2010, In: Vaccine. 28, 18, p. 3231-7 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine
Jenny Herbert, Sian Faustini, Alex Richter & Timothy Mitchell, 18 Jun 2018, In: Vaccine. 36, 26, p. 3809-3819 11 p.Research output: Contribution to journal › Article › peer-review
- Published
Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate
Roger Lock, Timothy Mitchell, Aug 1994, In: Vaccine. 12, 10, p. 875-8 4 p.Research output: Contribution to journal › Article › peer-review
- Published
The economic cost of measles: healthcare, public health and societal costs of the 2012-13 outbreak in Merseyside, UK
Deirdre Blissett, Hugh McLeod, 4 Apr 2016, In: Vaccine. 34, 15, p. 1823-31 9 p.Research output: Contribution to journal › Article › peer-review
- Published
The effectiveness of pneumococcal polysaccharide vaccines in adults: A systematic review of observational studies and comparison with results from randomised controlled trials
Jacqueline Dinnes, 13 Aug 2004, In: Vaccine. 22, 23-24, p. 3214-3224 11 p.Research output: Contribution to journal › Article › peer-review
- Published
Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999–2010
Timothy Mitchell, 23 Jul 2014, In: Vaccine. 32, 34, p. 4356-4363Research output: Contribution to journal › Article › peer-review
- Accepted/In press
Understanding the role of peace of mind in childhood vaccination: a qualitative study with members of the general public
Hareth Al-Janabi, 5 Dec 2019, (Accepted/In press) In: Vaccine.Research output: Contribution to journal › Article › peer-review
- Review article › Research › Not peer-reviewed
- Published
Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review
Yen-Fu Chen & Ian Litchfield, 1 Dec 2008, In: Vaccine. 26, 52, p. 6768-6776 9 p.Research output: Contribution to journal › Review article
- Published
The immune response to rabies virus infection and vaccination
Adam Cunningham, 1 May 2010, In: Vaccine. 28, 23, p. 3896-3901 6 p.Research output: Contribution to journal › Review article